Raw One for Women
Product analysis
Raw One for Women offers broad nutritional support for normal energy use, blood formation and bone maintenance when intake is low. Unidentified blends make the complete formula harder to assess.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality38
Manganese has a favorable identified form, but most other nutrients cannot be confidently compared for absorption. The molybdenum source and unnamed botanical preparations leave additional uncertainty.
Ingredient Transparency76
Amounts are stated throughout, and most nutrient sources or forms are named. Two blends have unidentified contents, preventing a complete check of the formula.
Value For Money46
The serving cost is favorable for vitamin K and manganese, while iron offers moderate value. Most other nutrient contributions remain difficult to compare for value.
Customer Satisfaction92
Customer ratings are very positive across a large review base. No specific experiences explain which features buyers found useful.
Product Focus14
The formula provides broad nutrition, with benefits most likely when a dietary shortfall is present. The unidentified blends prevent a complete assessment, and the nutritional roles do not establish additional longevity or heart protection.
- Format
Capsule - Container
- 75 Capsule(s)
- Per serving
- $0.37
- Customer rating
- 4.8 · 7,935 ratings
Goals
B vitamins supply nutrients used in normal energy metabolism and blood formation. Selenium supplies a nutrient involved in normal immune and antioxidant functions. Vitamin D and Vitamin K contribute to mineral nutrition and bone maintenance. Iron is useful when low intake contributes to iron deficiency. The nutritional contributions are most useful when intake is low; extra benefit with adequate intake is not established.
How this product is rated for Everyday Health
Ingredient fit84
Goal fit
Dose adequacy
Pathways100
Depth
Breadth
Evidence82
Evidence strength
Studied preparation
Formulation logic100
Partner coverage
Conflicts
Effective doses
Vitamin D and B12 support muscle, bone and neurological function, especially when a dietary gap exists. Vitamin C contributes to collagen formation, while vitamin E and selenium participate in antioxidant defenses. Folate and zinc add nutritional support, without established additional longevity benefits in well-nourished adults.
How this product is rated for Longevity
Ingredient fit52
Goal fit
Dose adequacy
Pathways43
Depth
Breadth
Evidence83
Evidence strength
Studied preparation
Formulation logic100
Partner coverage
Conflicts
Effective doses
Thiamin and selenium can address deficiencies linked to heart disease, without established extra benefit when intake is adequate. Folate supports homocysteine metabolism, but lowering that marker does not establish routine cardiovascular protection. B6 and B12 fall below the saved inclusion threshold. K1 does not match the specific MK-7 arterial-stiffness evidence, and vitamin D does not establish routine event prevention.
How this product is rated for Heart Health
Ingredient fit59
Goal fit
Dose adequacy
Pathways60
Depth
Breadth
Evidence89
Evidence strength
Studied preparation
Formulation logic100
Partner coverage
Conflicts
Effective doses
Folate gives this formula its main connection to homocysteine metabolism. Changes in homocysteine do not establish fewer cardiovascular events, and the favorable folate findings apply to specific population and treatment settings. Thiamin can help correct deficiency-related impairment of heart function. The other retained nutrients broaden nutritional coverage, but vitamin D and the declared vitamin K do not establish routine cardiovascular protection.
How this product is rated for Cardiovascular Support
Ingredient fit56
Goal fit
Dose adequacy
Pathways58
Depth
Breadth
Evidence69
Evidence strength
Studied preparation
Formulation logic100
Partner coverage
Conflicts
Effective doses
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Vitamin A (Beta-Carotene) | 900 mcg | |
Vitamin C (organic Amla) | 90 mg | |
Vitamin D (D3) | 25 mcg | |
Vitamin E (D-Alpha-Tocopherol) | 15 mg | |
Vitamin K (K1) | 120 mcg | |
Thiamin (S. cerevisiae) | 1.2 mg | |
Riboflavin (S. cerevisiae) | 1.3 mg | |
Niacin (Niacinamide) | 16 mg | |
Vitamin B6 (S. cerevisiae) | 1.7 mg | |
Folate (S. cerevisiae) | 800 mcg DFE | |
Vitamin B12 (Methylcobalamin) | 4.8 mcg | |
Biotin (S. cerevisiae) | 30 mcg | |
Pantothenic Acid (S. cerevisiae) | 5 mg | |
Iron (Brown Rice Chelate) | 5.4 mg | |
Zinc (Brown Rice Chelate) | 5.5 mg | |
Selenium (S. cerevisiae) | 27.5 mcg | |
Manganese (Brown Rice Chelate) | 2.3 mg | |
Chromium (S. cerevisiae) | 35 mcg | |
Molybdenum (Brown Rice Chelate) | 45 mcg | |
organic Emblic (Amla, Phyllanthus emblica) fruit extract | 200 mg | |
Raw Organic Fruit & Vegetable Blend | 20 mg | |
Raw Probiotic & Enzyme Blend | 8 mg |
How this ingredient is rated
Active Ingredient Quality & Bioavailability70
Manganese Chemical Form
Dose, Safety & Label Transparency86
Manganese Dosage Efficacy & Safety
Elemental Weight Disclosure
Value80
Price per Serving vs. Median
How this ingredient is rated
Active Ingredient Quality & Bioavailability0
Iron Chemical Form & Bioavailability
Absorption Support & Blocker Avoidance
Dose, Safety & Label Transparency70
Elemental Iron Label Clarity
Dosage Effectiveness & Safety Range
Value50
Price per Effective Serving
How this ingredient is rated
Active Ingredient Quality & Bioavailability0
Molybdenum Chemical Form
Branded or Patented Source
Dose, Safety & Label Transparency64
Elemental Dose Optimization
Upper Limit (UL) Safety Compliance
Value80
Price per Effective Serving
Alternative products
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Associations of dietary folate, vitamin B6 and B12 intake with cardiovascular outcomes in 115664 participants: a large UK population-based cohort.
- Folate, Homocysteine, and Adverse Outcomes After Ischemic Stroke.
- Effect of folic acid on endothelial function following acute myocardial infarction.
- Folic acid enhances endothelial function and reduces blood pressure in smokers: a randomized controlled trial.
- 5-methyltetrahydrofolate, the active form of folic acid, restores endothelial function in familial hypercholesterolemia.
- The current state of niacin in cardiovascular disease prevention: a systematic review and meta-regression.
- Effects of niacin on apo A1 and B levels: a systematic review and meta-analysis of randomised controlled trials.
- Effect of lipid-lowering therapies on lipoprotein(a) levels: a comprehensive meta-analysis of randomized controlled trials.
- Extended-release niacin vs gemfibrozil for the treatment of low levels of high-density lipoprotein cholesterol. Niaspan-Gemfibrozil Study Group.
- Equivalent efficacy of a time-release form of niacin (Niaspan) given once-a-night versus plain niacin in the management of hyperlipidemia.
- Effect of supplementation with high-selenium yeast on plasma lipids: a randomized trial.
- Association of selenium and cadmium with heart failure and mortality based on the National Health and Nutrition Examination Survey.
- Higher serum selenium concentration is associated with lower risk of all-cause and cardiovascular mortality among individuals with chronic kidney disease: A population-based cohort study of NHANES.
- Selenium status in the body and cardiovascular disease: a systematic review and meta-analysis.
- Associations of selenium status with all-cause and cause-specific mortality: a systematic review and meta-analysis of cohort studies.
- Vitamin B12 Status and Cardiovascular Risk: Novel Insights from NMR-Based Lipoprotein Profiling in 20,665 Adults.
- Pregnancy Metal Mixtures and Blood Pressure and Hypertension in Mid-Life: A Prospective U.S. Cohort Study.
- Vitamin B12 Deficiency, Hyperhomocysteinemia, and Diabetes as Metabolic Determinants of Cardiovascular Risk in Mexican Women.
- Impact of serum vitamin (Vitamin D, Vitamin B12) and trace element (Fe, Zn, Cu) levels on major adverse cardiovascular events and poor prognosis in STEMI patients undergoing primary PCI.
- Vasoplegic syndrome after cardiovascular surgery: A review of pathophysiology and outcome-oriented therapeutic management.